Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Investigational

Study on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

Registered drug

Hungary

Participants:0–17 years · 18–64 years · 65+ years
Substances:Jnj-77242113

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Envudeucitinib

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Registered drug

Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Ly4100511

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Hungary

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 3

67 trials match your criteria

Ischaemic stroke

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Dermatitis atopic

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Hypercholesterolaemia

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Hypertriglyceridaemia

Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

Rheumatoid arthritis

Study on the Effects of IMVT-1402 for Adults with Difficult-to-Treat Rheumatoid Arthritis

Psoriasis

Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

Psoriasis

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Psoriasis

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Psoriatic arthropathy

Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

Psoriasis

Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

Psoriatic arthropathy

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Dermatitis atopic

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.